rs8192859

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001061.7(TBXAS1):​c.1135-12229C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.145 in 152,232 control chromosomes in the GnomAD database, including 2,041 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 2041 hom., cov: 32)

Consequence

TBXAS1
NM_001061.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.799

Publications

6 publications found
Variant links:
Genes affected
TBXAS1 (HGNC:11609): (thromboxane A synthase 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TBXAS1 Gene-Disease associations (from GenCC):
  • ghosal hematodiaphyseal dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.207 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001061.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
NM_001061.7
MANE Select
c.1135-12229C>T
intron
N/ANP_001052.3P24557-1
TBXAS1
NM_001166253.4
c.1273-12229C>T
intron
N/ANP_001159725.2P24557-3
TBXAS1
NM_001130966.5
c.1135-12229C>T
intron
N/ANP_001124438.2P24557-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
ENST00000448866.7
TSL:1 MANE Select
c.1135-12229C>T
intron
N/AENSP00000402536.3P24557-1
TBXAS1
ENST00000336425.10
TSL:1
c.1135-12229C>T
intron
N/AENSP00000338087.7P24557-1
TBXAS1
ENST00000425687.5
TSL:1
c.934-12229C>T
intron
N/AENSP00000388736.1P24557-2

Frequencies

GnomAD3 genomes
AF:
0.145
AC:
21998
AN:
152114
Hom.:
2040
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0572
Gnomad AMI
AF:
0.0998
Gnomad AMR
AF:
0.104
Gnomad ASJ
AF:
0.126
Gnomad EAS
AF:
0.00289
Gnomad SAS
AF:
0.202
Gnomad FIN
AF:
0.182
Gnomad MID
AF:
0.143
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.127
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.145
AC:
22009
AN:
152232
Hom.:
2041
Cov.:
32
AF XY:
0.141
AC XY:
10514
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0571
AC:
2375
AN:
41558
American (AMR)
AF:
0.104
AC:
1594
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.126
AC:
436
AN:
3470
East Asian (EAS)
AF:
0.00289
AC:
15
AN:
5182
South Asian (SAS)
AF:
0.203
AC:
981
AN:
4826
European-Finnish (FIN)
AF:
0.182
AC:
1927
AN:
10598
Middle Eastern (MID)
AF:
0.147
AC:
43
AN:
292
European-Non Finnish (NFE)
AF:
0.210
AC:
14280
AN:
67990
Other (OTH)
AF:
0.126
AC:
267
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
928
1856
2783
3711
4639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.180
Hom.:
5998
Bravo
AF:
0.130
Asia WGS
AF:
0.0840
AC:
295
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.7
DANN
Benign
0.59
PhyloP100
0.80
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8192859; hg19: chr7-139694661; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.